Mitigating Inspection Findings Related to EU Clinical Trials Gaps – regulatory affairs consulting services Mitigating Inspection Findings Related to EU Clinical Trials Gaps As regulatory landscapes evolve, navigating the complexities of compliance in clinical trials becomes increasingly critical. For stakeholders involved in EU Clinical Trials, understanding how to mitigate inspection findings is paramount. This article serves as a step-by-step guide aimed at professionals in regulatory affairs consulting services, detailing essential strategies to address gaps in compliance. Through this comprehensive approach, organizations can strengthen their operations amidst scrutiny from regulatory authorities such as the European Medicines Agency (EMA) and local health…